We welcome you to Dundee on the 4th of December to learn about the latest pain research in Scotland and to hear from our keynote speakers Annina B Schmid @anninaschmid.bsky.social and Neil O'Connell @neiloconnell.bsky.social Call for abstracts and registration will open in August!
#painresearch
Too many students are convinced by their own universities, by some of their teachers and professors, and by the AI companies themselves that ‘using ai to study is getting ahead of the game’
But the process they seek to get ahead of is the point.
BMJ Open article: "Substantial undisclosed financial COIs were identified among the top 10 earners in high-impact psychiatry journals."
bmjopen.bmj.com/content/15/1...
Did you know @iasp.bsky.social’s #GlobalYear2026 is about neuropathic pain? Listen to the newest episode of Pain Exchange, featuring President Andrew Rice, @lampertlab.bsky.social, and @neiloconnell.bsky.social speaking about the goals of the campaign and more bit.ly/49S5XsZ
We've got ISSUES. Literally.
We scraped >100k special issues & over 1 million articles to bring you a PISS-poor paper. We quantify just how many excess papers are published by guest editors abusing special issues to boost their CVs. How bad is it & what can we do?
arxiv.org/abs/2601.07563
A 🧵 1/n
Global Year 2026
The 2026 IASP Global Year will focus on neuropathic pain. Neuropathic pain affects millions worldwide and can cause serious disability and reduced quality of life. IASP’s 2026 Global Year explores its challenges and best practices in diagnosis and treatment. #GlobalYear2026 bit.ly/49eE3Y1
Image with Cochrane logo and text stating no clear evidence that cannabis-based medicines relieve chronic nerve pain. Below, a person in a white blouse, holding a brown pill bottle, stands beside green plants.
There is no clear evidence that cannabis-based medicines provide pain relief for chronic neuropathic pain, an updated Cochrane review finds.
Read more here: www.cochrane.org/about-us/new...
** NEW PAPER in BMJ **
"AMSTAR-PF: a critical appraisal tool for systematic reviews of prognostic factor studies"
Allows the quality of prognostic factor reviews to be examined.
Brilliantly led by Michael L Henry.
www.bmj.com/content/391/...
@campbellreviews.bsky.social @iasp-mesisig.bsky.social
Did you ask Santa for a critical appraisal tool for systematic reviews of prognostic factor studies? The new AMSTAR-PF tool is now published in @bmj.com www.bmj.com/content/391/...
Excellent work from Michael Henry @UNISA driving this project.
@cochranesmg.bsky.social @jbiebhc.bsky.social
Out today in @annalsofim.bsky.social
doi.org/10.7326/ANNA...
Our systematic review of 11 RCTs found bisphosphonates may reduce short-term pain but increase risk for AEs. Results limited by substantial, unexplained heterogeneity, introduced by inclusion of terminated trial data.
Noteworthy that of the 2 institutional representatives, one thought there weren’t enough cases for an independent agency, other worried they’d be overwhelmed
Nice summary of advances in pain research in 2025 just out in Lancet Neurology: www.thelancet.com/journals/lan...
Great to see ENTRUST-PE get a solid nod! entrust-pe.org
As an accompaniment to this new perspective piece on measuring harms in pain research, the recording of our webinar "Assessing harms in pain research" is now available.
@iasp.bsky.social @iasp-mesisig.bsky.social @efic.bsky.social @britishpainsoc.bsky.social
perc.iasp-pain.org/methodology-...
Our recent and excellent @iasp-mesisig.bsky.social webinar "Optimising Openness and Transparency in Pain Research" is now free to view here perc.iasp-pain.org/methodology-...
New systematic review focused on amputation for complex regional pain syndrome and briliantly led by @yannickgilanyi.bsky.social from UNSW and Neura
sciencedirect.com/science/arti...
HT @iasp.bsky.social @iasp-mesisig.bsky.social @britishpainsoc.bsky.social @efic.bsky.social @usasp.bsky.social
🚨 BPS Endorses the ENTRUST-PE Framework
The British Pain Society is proud to endorse ENTRUST-PE – a framework boosting the trustworthiness, transparency, and rigor of pain research.
🔗Read more: m.entrust-pe.org
youtu.be/_zephafiitk?...
Great to see the OPTIMETH framework for optimising clinical trials in CRPS, brilliantly led by Keith Smart from @ucddublin.bsky.social now out in @painreports.bsky.social
journals.lww.com/painrpts/ful...
@britishpainsoc.bsky.social @efic.bsky.social @iasp.bsky.social @iasp-mesisig.bsky.social
MESISIG is now on BlueSky. We've migrated who we follow 9as far as possible) from X but do please follow us back. We promise all things methodology and pain research!
Registration and reporting will become mandatory for all clinical trials next year. It's good to see many trial sponsors already delivering on this, but with clear @hralatest.bsky.social guidance, no excuse for anyone not to be transparent about results #AllTrials
www.hra.nhs.uk/planning-and...
To do no harm, we must first “know harms”
Our new perspective piece on the
challenge of measuring and reporting adverse
events in interventions for pain is now available in @painthejournal.bsky.social dx.doi.org/10.1097/j.pa...
@iasp.bsky.social @efic.bsky.social @britishpainsoc.bsky.social
www.medrxiv.org/content/10.1...
INSPECT-SR: A tool for assessing trustworthiness of randomised controlled trials.
To do no harm, we must first “know harms”
Our new perspective piece on the
challenge of measuring and reporting adverse
events in interventions for pain is now available in @painthejournal.bsky.social dx.doi.org/10.1097/j.pa...
@iasp.bsky.social @efic.bsky.social @britishpainsoc.bsky.social
📣 Save the date for the 12th PCI webinar on September 18, 2025, at 4 PM CET!! Dorothy Bishop (@deevybee.bsky.social) will present "Editors matter: How negligent publishers subvert quality control in scientific publishing ". For more details and registration, visit:
@efic.bsky.social @britishpainsoc.bsky.social @auspainsoc.bsky.social
Out today 🚨 Our Cochrane review of 67 RCTs finds no clear evidence of benefit for ketamine or other NMDA antagonists for chronic pain. IV ketamine associated with risk of psychotomimetic effects, nausea, and vomiting. doi.org/10.1002/1465...
The ENTRUST-Pain Evidence (Entrust-PE) is an important initiative to ensure that pain science is of high quality.
Framework published in J Pain.
Endorsed by @iasp.bsky.social & @efic.bsky.social.
More here: m.entrust-pe.org
#pain
Editorial: The editors-in-chief from @thejournalofpain.bsky.social & other pain/anesthesia journals come together to align and strengthen initiatives to enhance research integrity, trust, and impact across our field.
Full: www.jpain.org/article/S152...